← Leaderboards
George Ioannou
Va Puget Sound Healthcare System
$2,167,138
Attributed
$2,865,121
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,555,203 · 7
VA$0 · 4
By mechanism
P20$4,159,237 · 5
R01$984,996 · 1
R21$410,970 · 1
I01$0 · 4
Top collaborators
- Noel Weiss4 shared
- William M Grady3 shared
- Brian James Mcmahon3 shared
- James A Fogarty2 shared
Others in their field
Top investigators on “Cirrhosis”
- Russell E Ware · Duke University$30,715,534
- Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System$28,844,065
- Anna Mae Elizabeth Diehl · Johns Hopkins University$25,083,421
- Charles M. Rice · Rockefeller University$24,697,583
- Merrill E Gershwin · University Of California At Davis$23,357,355
- Raymond T Chung · Massachusetts General Hospital$18,086,371
Research focus
CirrhosisMortalityObesityDiabetes MellitusPrimary Carcinoma Of The Liver CellsCessation Of LifePersonsPrevalenceHepatitis BRisk FactorsInnovationPreventDesignCaringStructureVeteransFunctional DisorderReportingProgramsIncidenceScreeningResearch PersonnelMalignant Neoplasm Of LiverMedical
Grant awards (37)
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2025 · VA · contact PI
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2024 · VA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$828,416
P20 · FY2023 · CA · contact PI
Risk stratification strategies and abbreviated MRI-based surveillance for early detection of HCC in high-risk AI/AN patients$200,850
P20 · FY2023 · CA · contact PI
Administrative Core$190,954
P20 · FY2023 · CA · contact PI
Developmental Research Program$63,924
P20 · FY2023 · CA · contact PI
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2023 · VA · contact PI
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2023 · VA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$850,177
P20 · FY2022 · CA · contact PI
Risk stratification strategies and abbreviated MRI-based surveillance for early detection of HCC in high-risk AI/AN patients$202,794
P20 · FY2022 · CA · contact PI
Administrative Core$196,742
P20 · FY2022 · CA · contact PI
Developmental Research Program$63,923
P20 · FY2022 · CA · contact PI
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2022 · VA · contact PI
Liver Cancer Disparities in Alaska Native and American Indian People$1,011,489
P20 · FY2021 · CA · contact PI
Risk stratification strategies and abbreviated MRI-based surveillance for early detection of HCC in high-risk AI/AN patients$262,630
P20 · FY2021 · CA · contact PI
Administrative Core$222,109
P20 · FY2021 · CA · contact PI
Developmental Research Program$65,229
P20 · FY2021 · CA · contact PI
Cholesterol lights the fire of NASH$0
I01 · FY2021 · VA · contact PI
Evaluating a novel, portable, self-administered device ("Flicker-App") that measures critical flicker frequency as a test for minimal hepatic encephalopathy in cirrhosis$187,517
R21 · FY2020 · DK · contact PI
Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?$0
I01 · FY2020 · VA · contact PI
Cholesterol lights the fire of NASH$0
I01 · FY2020 · VA · contact PI
Development and Validation of a Cirrhosis-specific Surgical Risk Calculator (C-SuRC)$0
I01 · FY2020 · VA · contact PI
Evaluating a novel, portable, self-administered device ("Flicker-App") that measures critical flicker frequency as a test for minimal hepatic encephalopathy in cirrhosis$223,453
R21 · FY2019 · DK · contact PI
Cholesterol lights the fire of NASH$0
I01 · FY2019 · VA · contact PI
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$273,336
R01 · FY2018 · CA · contact PI
Cholesterol lights the fire of NASH$0
I01 · FY2018 · VA · contact PI
Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?$0
I01 · FY2018 · VA · contact PI
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$273,336
R01 · FY2017 · CA · contact PI
Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?$0
I01 · FY2017 · VA · contact PI
Cholesterol lights the fire of NASH$0
I01 · FY2017 · VA · contact PI
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$209,012
R01 · FY2016 · CA · contact PI
Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?$0
I01 · FY2016 · VA · contact PI
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?$229,312
R01 · FY2015 · CA · contact PI
Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?$0
I01 · FY2015 · VA · contact PI
Is HIV-associated lipodystrophy a risk factor for cirrhosis of the liver?$0
I01 · FY2013 · VA · contact PI
Is HIV-associated lipodystrophy a risk factor for cirrhosis of the liver?$0
I01 · FY2012 · VA · contact PI
Is HIV-associated lipodystrophy a risk factor for cirrhosis of the liver?$0
I01 · FY2011 · VA · contact PI